Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population

NCT ID: NCT03541954

Last Updated: 2022-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-17

Study Completion Date

2022-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess and validate the clinical criteria of sensitization ("Convergences PP criteria") selected by the expert consensus with neurophysiological sensory testing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Some patient with chronic pelvic or perineal pain, present complex manifestations, comprising pain and dysfunction which does not involved a single organ. The gap between clinical symptoms and pathological signs is a constant feature of these pain syndromes. A possible explanation for these pain syndromes is central sensitization. This sensitization is defined by decrease nociceptive thresholds, a more intense and more prolonged response to nociceptive stimulus, and spatial extension of the painful area. It has been defined by international expert consensus in 2016 a clinical evaluation tool with 10 criteria for sensitization diagnosis: Convergences PP criteria. The aim of this study is to objectivize lower threshold, spatial and temporal diffusion of pain in women with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5) compared to women without sensitization (Convergences PP criteria \< 5). A sensory testing of lower urinary tract, lower rectal tract, vulva and pelvic muscles will be achieved.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pelvic Pain Chronic Perineal Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

2 types of patients will be included:

* 30 patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5)
* 30 patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria \< 5)
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient with pelvic or perineal pain with sensitization

Patients with chronic pelvic or perineal pain with sensitization (Convergences PP criteria \> 5)

Group Type OTHER

Sensory testing of lower urinary tract.

Intervention Type OTHER

Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.

Sensory testing of lower rectal tract

Intervention Type OTHER

Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).

Sensory testing of vulva muscles

Intervention Type OTHER

Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.

Sensory testing of pelvic muscles

Intervention Type OTHER

Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.

Patient with pelvic or perineal pain without sensitization

Patients with chronic pelvic or perineal pain without sensitization (Convergences PP criteria \< 5)

Group Type OTHER

Sensory testing of lower urinary tract.

Intervention Type OTHER

Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.

Sensory testing of lower rectal tract

Intervention Type OTHER

Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).

Sensory testing of vulva muscles

Intervention Type OTHER

Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.

Sensory testing of pelvic muscles

Intervention Type OTHER

Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sensory testing of lower urinary tract.

Non invasive lower urinary tract sensitivity testing: provoked diuresis with sonographic estimates of sensory thresholds.

Intervention Type OTHER

Sensory testing of lower rectal tract

Lower digestive tract sensitivity testing: rectal electronic barostat with ascending pressure (phasic distension).

Intervention Type OTHER

Sensory testing of vulva muscles

Vulvar sensitivity testing: pressure pain threshold evaluated using vulvagesiometer.

Intervention Type OTHER

Sensory testing of pelvic muscles

Myofascial sensitivity testing: piriformis, levator ani and obturator internus muscles pressure pain threshold evaluated using intra-vaginal algometer.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women \> 25 years,
* Pelvic or perineal pain since \> 3 months,
* No injury in pelvic imagery or clinical examination that may explain all the pain complaint,
* Patient who can understand the protocol,
* Patient who agreed and signed the informed consent for participation.

Exclusion Criteria

* Poor understanding of French language,
* Pregnancy or lactation,
* Severe depression (Beck Depression Inventory-Short form \> 16),
* Initial pain estimation at 10 on numeric analog scale,
* Inadequately cooperating,
* Isolated dysmenorrhea,
* Deep endometriosis with rectal or bladder lesion,
* Genital or bladder infection,
* Urogenital tumor history,
* Anorectal surgery history a type of digestive resection,
* Anal stenosis,
* Advanced vaginal prolapse (stage 2 on POP-Q scale),
* Post-traumatic stress disorder history,
* Deprived of liberty (trusteeship, guardianship).
Minimum Eligible Age

25 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nantes university Hospital

Nantes, , France

Site Status

Groupe Confluent

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cardaillac C, Levesque A, Riant T, Mortier A, Neunlist M, Perrouin-Verbe MA, Volteau C, Thubert T, Brochard C, Ploteau S. Evaluation of a scoring system for the detection of central sensitization among women with chronic pelvic pain. Am J Obstet Gynecol. 2023 Nov;229(5):530.e1-530.e17. doi: 10.1016/j.ajog.2023.07.044. Epub 2023 Jul 27.

Reference Type DERIVED
PMID: 37516398 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC17_0427

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multidisciplinary Treatment of Chronic Vulvar Pain
NCT03640624 ACTIVE_NOT_RECRUITING NA
Vulvodynia Pain Thresholds
NCT04461210 TERMINATED